Background and Aims:
Chronic migraine imposes a considerable economic burden and is closely linked to other health conditions, Early detection of migraine-associated factors allows for timely interventions, impacting prevention, treatment, and prognosis.
Methods:
A descriptive cross-sectional study at King Fahad Hospital in Jeddah, Saudi Arabia, included 82 chronic migraine patients receiving botulinum toxin injections. This study explores the correlation between sleep quality and chronic migraine severity, investigates the relationship between vitamin D levels and migraines, and identifies predictors of poor sleep quality in the studied patient population.
Results:
Our patient cohort, aged 21 to 63, is predominantly female (87.8%), with 50% having a university education. Surprisingly, less than 10% maintained adequate vitamin D levels. Nearly two-thirds, especially among the younger age group, those with chronic diseases, and smokers, faced moderate to severe disability due to migraines. Additionally, over half of the patients, particularly in the older age group, females, and those with lower education levels, experienced poor sleep quality, with a higher likelihood linked to lower vitamin D levels and more severe migraine scores.
Conclusions:
These results underscore the significance of early detection in migraines, facilitating timely interventions for prevention, treatment, and prognosis. The complex interaction of sleep quality, migraine severity, and vitamin D levels highlights the necessity for holistic approaches to improve the well-being of individuals dealing with chronic migraines.
Key words: Botulinum toxin, MIDAS, Migraine, PSQS, sleep quality, vitamin D.
|
